Clinical Trials Browser

Withdrawn × Estramustine × Clear all

NCT02853071 2019-11-18

BEST

Phase 2 Withdrawn

Breast Neoplasms

NCT00084565 2013-07-10

Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate Cancer

Phase 2 Withdrawn

Prostatic Neoplasms